Resultados: 37

Apixaban for preventing recurrence of ischemic stroke in patients with atrial cardiopathy: a systematic review and meta-analysis

Stroke; 56 (Suppl.1), 2025
INTRODUCTION: Preventing ischemic strokes in patients with atrial cardiopathy is particularly challenging due to the elevated risks associated with the condition. While numerous studies have established the efficacy of anticoagulants in preventing stroke, their benefits for patients with atrial cardiopat...

Stroke risk in cancer survivors: a systematic review and meta-analysis

Stroke; 56 (Suppl.1), 2025
BACKGROUND: It is suggested that survivors of different types of cancer may have an increased risk of stroke. Our study aims to evaluate cancer patients and non-cancer controls by analyzing stroke events in each group. Previous studies concluded that certain types of cancer increased stroke risk, however...

Effects of Tirofiban on early neurological deterioration in patients with acute ischemic stroke: a systematic review and meta- analysis

Stroke; 56 (Suppl.1), 2025
INTRODUCTION: Early neurological deterioration (END) is an adverse outcome of acute ischemic stroke that affects up to one-third of patients and is linked to poorer functional outcomes. Tirofiban, a nonpeptide glycoprotein IIb/IIIa receptor blocker, is widely used in the treatment of atherosclerotic hear...

Outcomes of Transcatheter Aortic Valve Implantation (TAVI) in patients with bicuspid aortic valve: a single-center experience

Int. j. cardiovasc. sci. (Impr.); 37 (suppl. 13), 2024
INTRODUCTION: Bicuspid aortic valve (BAV) is the most common congenital cardiac abnormality, occurring in 1% to 2% of the total population and can reach up to 25% in patients (pts) aged 80 years or older referred for TAVI. However, this condition has been excluded from major randomized studies. Recently,...

Net benefit of closure of patent forame oval in reduction of stroke rates: update meta analisys with randomized controlled trial and observational cohorts with propensity score matched studies

Int. j. cardiovasc. sci. (Impr.); 37 (suppl. 13), 2024
BACKGROUND: Cryptogenic strokes, accounting for 40% of acute ischemic strokes, are linked to patent foramen ovale (PFO). Despite research efforts, uncertainties remain about optimal prevention strategies. OBJECTIVES: Therefore, we aimed to review RCTs and Propensity Score Matching (PSM) Studies comparing...

Estratificação de risco na prevenção primária e secundária da doença aterosclerótica: papel dos novos escores de risco
Risk stratification in primary and secondary prevention of atherosclerotic disease: the role of new risk scores

Diretrizes médicas recomendam avaliar o risco cardiovascular usando escores para auxiliar a tomada de decisão clínica. A efetiva comunicação do risco ao paciente pode melhorar a conscientização sobre sua condição e a adesão ao tratamento. Vários escores de risco cardiovascular foram desenvolvi...

"Fique atento aos sinais de disfagia" - Uma campanha para a conscientização da disfagia associada às doenças cardiovasculares
"Be aware of the signs of dysphagia" - A campaign to raise awareness of dysphagia associated with cardiovascular disease

INTRODUÇÃO: A atuação fonoaudiológica no público com doenças cardiovasculares tem enforque nos três níveis de atenção à saúde, primária, secundária e terciária. Essa população abrange na grande maioria a população idosa, com maior porporção aos idosos frágeis, com riscos cardiovasc...

Discontinuation vs continuation of renin-angiotensin system inhibition before non-cardiac surgery: a systematic review and meta-analysis

Circulation; 150 (Suppl. 1), 2024
BACKGROUND: The optimal management of angiotensin-converting enzyme (ACE) inhibitors during elective surgeries remains uncertain. While some studies suggest that continuing ACE inhibitors increase the risk of perioperative hypotension, others argue that discontinuation may heighten the risk of significan...

DOACs versus aspirin for secondary prevention of stroke after ESUS: an updated systematic review and meta-analysis of randomized clinical trials

Circulation; 150 (Suppl. 1), 2024
BACKGROUND: Embolic stroke of undetermined source (ESUS) is a nonlacunar ischemic stroke with no clear cause, having a 4%-5% annual recurrence rate. The potential benefits of direct oral anticoagulants (DOACs) relative to aspirin in patients with ESUS remain unclear. OBJECTIVE: We aimed to perform a syst...

Artificially sweetened beverages and cardiovascular events: a meta-analysis of nearly one million cohort patients

Circulation; 150 (Suppl. 1), 2024
BACKGROUND: With the rising use of artificial sweeteners as sugar substitutes, concerns regarding their impact on cardiovascular health have emerged. Despite approval by national food regulatory agencies, evidence of their association with clinically significant cardiovascular events remains inconclusive...